Loading...

Roche Holding AG

RHHVFPNK
HealthcareDrug Manufacturers - General
$317.00
$-3.90(-1.22%)

Roche Holding AG (RHHVF) Stock Overview

Explore Roche Holding AG’s financial performance, market position, analyst ratings, and future outlook.

Stats data is not available for RHHVFStats details for RHHVF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for RHHVFAnalyst Recommendations details for RHHVF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, and internationally. The company offers pharmaceutical products in the therapeutic areas of oncology, neuroscience, infectious diseases, immunology, hemophilia, ophthalmology, dermatology, respiratory, anemia, inflammatory and autoimmune, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, cardiovascular, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD). Roche Holding AG was founded in 1896 and is headquartered in Basel, Switzerland.

CEO

Dr. Thomas Schinecker

Employees

103,249

Headquarters

Grenzacherstrasse 124, Basel

Founded

2009

Frequently Asked Questions